MYLAN 73 (Amitriptyline and perphenazine 50 mg / 4 mg)
Pill imprint MYLAN 73 has been identified as Amitriptyline and perphenazine 50 mg / 4 mg.
Amitriptyline/perphenazine is used in the treatment of depression; anxiety; agitation and belongs to the drug class psychotherapeutic combinations. FDA has not classified the drug for risk during pregnancy. Amitriptyline/perphenazine 50 mg / 4 mg is not a controlled substance under the Controlled Substance Act (CSA).
- MYLAN 73
- 50 mg / 4 mg
- 11.00 mm
- Prescription only
- Drug Class:
- Psychotherapeutic combinations
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium lauryl sulfate
D&C Red No. 7
FD&C Blue No. 1
Note: Inactive ingredients may vary.
More about amitriptyline/perphenazine
- Side Effects
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 5 Reviews – Add your own review/rating
- Drug class: psychotherapeutic combinations
- Amitriptyline and perphenazine
- Perphenazine and amitriptyline (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.